Global Life Sciences BPO Market Size By Service Type (Contract Research Organizations, Contract Sales And Marketing Organizations), By Application (Clinical Trials, Patient-Centric), By Geographic Scope And Forecast
Published on: 2024-08-07 | No of Pages : 320 | Industry : latest updates trending Report
Publisher : MIR | Format : PDF&Excel
Global Life Sciences BPO Market Size By Service Type (Contract Research Organizations, Contract Sales And Marketing Organizations), By Application (Clinical Trials, Patient-Centric), By Geographic Scope And Forecast
Life Sciences BPO Market Size And Forecast
Life Sciences BPO Market size was valued at USD 270.3 Billion in 2022 and is projected to reach USD 481.8 Billion by 2030, growing at a CAGR of 7.50% from 2024 to 2030.
The need for new drugs and novel therapies for the treatment of diseases such as cancer and immunological disorders coupled with the evolving research & development process has increased. The development of cellular therapy, biosimilar products, and immune biological products has funded the advancing pipeline and the need for stringent clinical trials. The Global Life Sciences BPO Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Global Life Sciences BPO Market Definition
Business process outsourcing, or BPO, is a subset of outsourcing in which one organization or company hires another company to perform a task that involves contracting the operations and responsibilities for a particular business process for its own business to operate successfully. Intelligent drug discovery, Gene therapies, and telemedicine are bringing a change in the Life Sciences BPO Market.
Most companies have now focused on life sciences BPO to speed up the time to market for the latest treatments and reduce the cost of R&D to adapt to complex markets. It helps to choose and implement the best business process solutions for the organization and helps to gain the most value from the investments. Companies use business process outsourcing mostly for the front-office and back-office tasks. This helps them to concentrate on their core strengths and in turn improve productivity.
What's inside a
industry report?
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
Global Life Sciences BPO Market Overview
The need for new drugs and novel therapies for the treatment of diseases such as cancer and immunological disorders coupled with the evolving research & development process has increased. The development of cellular therapy, biosimilar products, and immune biological products has funded the advancing pipeline and the need for stringent clinical trials. These factors drive the growth of the global Life Sciences BPO Market. Moreover, contract sales and marketing services are also projected to observe an increase in demand due to the growing sales and marketing segments for the new product launch over the forecast period.
However, stringent regulatory approval processes in different countries might hamper the overall market growth. Along with the slowdown in world economic growth, the Life Sciences BPO industry has also suffered a certain impact. Companies are using advanced technologies such as machine learning, and AI which opens up the opportunity inline in the Life Sciences BPO Market. In the pharmaceutical industry, growing cuts in government budgets and subsidies across developed markets are the main areas where more lucrative opportunities can be hunted.
Global Life Sciences BPO Market Segmentation Analysis
The Global Life Sciences BPO Market is Segmented on the basis of Service Type, Application, And Geography.
Life Sciences BPO Market, By Service Type
- Contract Research Organizations
- Contract Sales and Marketing Organizations
- Contract Manufacturing Organizations
- Others
Based on Service Type, the market is segmented into Contract Research Organizations, Contract Sales and Marketing Organizations, Contract Manufacturing Organizations, and Others. The Contract Research Organizations segment dominated the major market share within the life science BPO market. Pharmaceutical, biotechnology, and medical device businesses might use contract research organizations to do research and development (R&D). They provide services like managing clinical trials, managing data, consulting on regulatory issues, pharmacovigilance, and other research-related tasks. For life science firms, Contract Research Organizations are a vital resource in the process of drug discovery and development.
Life Sciences BPO Market, By Application
- Clinical Trials
- Patient-Centric
- R&D Activities
- Digital Era
Based on Application, the market is segmented into Clinical Trials, Patient-Centric, R&D Activities, and Digital Era. The life sciences industry is in its transformative stage where there is a growing need for effective medicines and personalized digital therapeutics that improve the quality of life in patients. RPA (Robotic Process Automation) technology and other software robots are therefore receiving more attention from organizations in the life sciences BPO industry to enable cognitive automation in pharmaceutical research.
Life Sciences BPO Market, By Geography
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East And Africa
Based on Geography, the Global Life Sciences BPO Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East And Africa. Asia Pacific is expected to grow at the fastest rate over the forecast period. India and China are the key hubs for the life sciences outsourcing market. India and China account for the majority of the active pharmaceutical ingredient (API) and finished product exports across the globe.
Key Players
The “Global Life Sciences BPO Market” study report will provide valuable insight with an emphasis on the global market. The major players in the market are IQVIA, Syneos Health Inc, Laboratory Corporation of America Holdings, Parexel International Corporation, Charles River Laboratories International, PRA Health Sciences Inc, WuXi AppTec Co. Ltd, Medpace Holdings Inc, ICON plc, Pharmaceutical Product Development LLC.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
Ace Matrix Analysis
The Ace Matrix provided in the report would help to understand how the major key players involved in this industry are performing as we provide a ranking for these companies based on various factors such as service features & innovations, scalability, innovation of product, industry coverage, industry reach, and growth roadmap. Based on these factors, we rank the companies into four categories as Active, Cutting Edge, Emerging, and Innovators.
Market Attractiveness
The image of market attractiveness provided would further help to get information about the region that is majorly leading in the Global Life Sciences BPO Market. We cover the major impacting factors that are responsible for driving the industry growth in the given region.
Porter’s Five Forces
The image provided would further help to get information about Porter’s five forces framework providing a blueprint for understanding the behavior of competitors and a player’s strategic positioning in the respective industry. Porter’s five forces model can be used to assess the competitive landscape in the global Life Sciences BPO Market, gauge the attractiveness of a certain sector, and assess investment possibilities.
Report Scope
REPORT ATTRIBUTES | DETAILS |
---|---|
STUDY PERIOD | 2019-2030 |
BASE YEAR | 2022 |
FORECAST PERIOD | 2024-2030 |
HISTORICAL PERIOD | 2019-2021 |
UNIT | Value (USD Billion) |
KEY COMPANIES PROFILED | IQVIA, Syneos Health Inc, Laboratory Corporation of America Holdings, Parexel International Corporation, Charles River Laboratories International, PRA Health Sciences Inc |
SEGMENTS COVERED |
|
CUSTOMIZATION SCOPE | Free report customization (equivalent up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope. |